Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/457
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLong, J.en
dc.contributor.authorSteadman, K. J.en
dc.contributor.authorClavarino, A.en
dc.contributor.authorSmith, P. J.en
dc.date.accessioned2018-06-16T20:34:11Z-
dc.date.available2018-06-16T20:34:11Z-
dc.date.issued2014en
dc.identifier.citationMarch 10, (1), 2014, p. 1-10en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/457-
dc.description.abstractComplementary and alternative medicine (CAM) cover a broad and diverse group of treatments and products that do not tend to be widely used by conventional healthcare professions. CAM that is systemically absorbed is the most likely to interfere with concurrent chemotherapy and potentially cause harm to cancer patients. Patients receiving chemotherapy may be consuming CAM to treat cancer, to lessen chemotherapy side effects, for symptom management, or to treat conditions unrelated to their cancer. A small proportion of cancer patients decide to use CAM alone to treat cancer and delay conventional treatment. Cancer patients may be influenced in their CAM decision-making by others: practitioners, family, friends, spouse and even casual acquaintances met in waiting rooms and support groups. This influence may range from encouraging and supporting the patient's decision through to making the decisions for the patient. When tested in rigorous clinical trials, no CAM cancer treatments alone have shown benefit beyond placebo. With the exception of ginger to treat chemotherapy-induced nausea, there is no compelling evidence overriding risk to take complementary medicines for supportive care during chemotherapy treatment. There is, however, established evidence to use mind-body complementary therapies for supportive care during chemotherapy treatment. 2013 Wiley Publishing Asia Pty Ltd.<br />en
dc.languageenen
dc.relation.ispartofAsia-Pacific Journal of Clinical Oncologyen
dc.titleWhy do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks?en
dc.typeArticleen
dc.identifier.doihttp://dx.doi.org/10.1111/ajco.12115en
dc.subject.keywordsChemotherapyComplementary and alternative medicineen
dc.subject.keywordsDecision-makingen
dc.subject.keywordsGroup 3: other specific research areasen
dc.subject.keywordsalternative medicineen
dc.subject.keywordscancer chemotherapyen
dc.subject.keywordscancer diagnosisen
dc.subject.keywordscancer patienten
dc.subject.keywordsclinical trial (topic)en
dc.subject.keywordsfamilyen
dc.subject.keywordsfrienden
dc.subject.keywordsgeneral practitioneren
dc.subject.keywordsgingeren
dc.subject.keywordshealth care personnelen
dc.subject.keywordshumanen
dc.subject.keywordsmedical decision makingen
dc.subject.keywordsnauseaen
dc.subject.keywordspriority journalen
dc.subject.keywordsquackeryen
dc.subject.keywordsreviewen
dc.subject.keywordsrisk assessmenten
dc.subject.keywordssafetyen
dc.subject.keywordsspouseen
dc.subject.keywordssupport groupen
dc.subject.keywordssymptomen
dc.subject.keywordstherapy delayen
dc.subject.keywordswaiting roomen
dc.subject.keywordsalkylating agenten
dc.subject.keywordsantimetaboliteen
dc.subject.keywordsantioxidanten
dc.subject.keywordscamptothecinen
dc.subject.keywordsplaceboen
dc.subject.keywordsplatinum derivativeen
dc.subject.keywordspodophyllinen
dc.subject.keywordstamoxifenen
dc.subject.keywordsVinca alkaloiden
dc.subject.keywordsyoghurten
dc.relation.urlhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed11&AN=2014127643en
dc.identifier.risid469en
dc.description.pages1-10en
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
Appears in Sites:Queensland Health Publications
Sunshine Coast HHS Publications
Show simple item record

Page view(s)

328
checked on May 21, 2026

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.